This registry highlights that PAH is often detected late, leading to severe functional and hemodynamic compromise at diagnosis.
No takes yet. Share an insight, caveat, or question.
Supports earlier PAH screening protocols in at-risk groups; leaves open outcome benefits pending prospective validation.
Humbert et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: